Publikationen in Zusammenarbeit mit Forschern von Hospital Morales Meseguer (24)

2023

  1. Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study

    Journal of medical virology, Vol. 95, Núm. 7, pp. e28933

  2. Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors

    British Journal of Haematology, Vol. 200, Núm. 6, pp. e58-e61

  3. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients

    Viruses, Vol. 15, Núm. 10

2021

  1. Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group

    Transplant Infectious Disease, Vol. 23, Núm. 4

  2. Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment

    Bone Marrow Transplantation, Vol. 56, Núm. 6, pp. 1281-1290

  3. Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group

    American Journal of Transplantation, Vol. 21, Núm. 1, pp. 258-271

  4. Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib

    British Journal of Haematology

  5. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

    The Journal of infectious diseases, Vol. 223, Núm. 9, pp. 1564-1575

2017

  1. IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients

    Journal of Medical Virology, Vol. 89, Núm. 4, pp. 685-695

2016

  1. Efficacy and safety of a preemptive antiviral therapy strategy based on combined virological and immunological monitoring for active cytomegalovirus infection in allogeneic stem cell transplant recipients

    Open Forum Infectious Diseases, Vol. 3, Núm. 2

2015

  1. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia

    Journal of Medical Virology, Vol. 87, Núm. 9, pp. 1601-1607

  2. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8+ T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation

    Transplant Infectious Disease, Vol. 17, Núm. 3, pp. 361-370

  3. Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes

    Journal of Medical Virology, Vol. 87, Núm. 2, pp. 248-255

2014

  1. An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation

    Journal of Medical Virology, Vol. 86, Núm. 5, pp. 806-811

  2. An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting

    Journal of Medical Virology, Vol. 86, Núm. 4, pp. 568-575

2012

  1. Functional profile of cytomegalovirus (CMV)-specific CD8 + T cells and kinetics of NKG2C + NK Cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients

    Journal of Medical Virology, Vol. 84, Núm. 2, pp. 259-267

2011

  1. Effect of cytomegalovirus (CMV) serostatus on the incidence and virological features of active CMV infection in allogeneic stem cell transplant recipients

    Clinical Infectious Diseases

  2. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8+ and CD4 + T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

    Bone Marrow Transplantation, Vol. 46, Núm. 11, pp. 1437-1443

  3. Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection

    Bone Marrow Transplantation

2010

  1. An Assessment of the Effect of Human Herpesvirus-6 Replication on Active Cytomegalovirus Infection after Allogeneic Stem Cell Transplantation

    Biology of Blood and Marrow Transplantation, Vol. 16, Núm. 5, pp. 653-661